Video

Examining Stress and Quality of Life in Bladder Cancer

Author(s):

Ahrang Jung

Patients with non-muscle invasive bladder cancer experience high levels of distress, according to one study.

Patients with non-muscle invasive bladder cancer have high levels of distress and post-traumatic stress disorder (PTSD) symptoms, according to research conducted by Ahrang Jung, a Ph.D., student at the University of North Carolina at Chapel Hill School of Nursing.

In her study, Jung found that about one if four patients with the disease experience PTSD symptoms. Factors that contribute to their stress include uncertainty for the future, especially when it comes to cancer recurrence, as well as frequently needed to undergo invasive testing.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.
Related Content
Illustration of bladder.
April 22nd 2025

Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment

Ryan Scott
Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder cancer, based on the NIAGARA trial.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Illustration of bladder.
April 16th 2025

FDA sBLA Submitted for Anktiva Plus BCG in Papillary Bladder Cancer

Alex Biese
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
cancer horizons podcast logo
December 20th 2023

FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

Alex Biese Brielle Benyon
The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.
April 7th 2025

Bavencio Has Long-Term Benefit Regardless of Diabetes Status in Bladder Cancer

Ryan Scott
Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.